Stress and prolactin effects on bone marrow myeloid cells, serum chemokine and serum glucocorticoid levels in mice

NeuroImmunoModulation

Volumn 14, Issue 6, 2007, Pages 287-296

  Dugan, Amy L ^a,b   Schwemberger, Sandy ^a   Noel, Greg J ^a   Babcock, George F ^a,b   Ogle, Cora K ^a,b   Buckley, Donna J ^b   Horseman, Nelson D ^a,b   Gregerson, Karen A ^a,b  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Bone marrow; Corticosterone; Myeloid cells; Prolactin; Psychological stress

Indexed keywords

CHEMOKINE; COLONY STIMULATING FACTOR 1; CORTICOSTERONE; CYTOKINE; GLUCOCORTICOID; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; PROLACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CLONOGENIC ASSAY; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HORMONE RELEASE; HYPERPROLACTINEMIA; IMMUNE SYSTEM; MOUSE; NONHUMAN; PREDATION; PRIORITY JOURNAL; PROLACTIN RELEASE; RADIOIMMUNOASSAY; STRESS;

ANIMALS; BEHAVIOR, ANIMAL; BONE MARROW CELLS; CHEMOKINES; FLOW CYTOMETRY; GLUCOCORTICOIDS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MYELOID CELLS; NEUROIMMUNOMODULATION; NEUTROPHILS; PROLACTIN; STRESS, PSYCHOLOGICAL;

EID: 44349100559     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000117810     Document Type: Article

References (39)

1. Bellone G, Geuna M, Carbane A, Silvestri S, Foa R, Matera L: Regulatory action of prolactin on the in vitro growth of CD34+ve human hemopoietic cells. J Cell Physiol 1995;163:221-231.
2. Knoferl M, Angele M, Ayaia A, Cioffi W, Bland K, Chaudry I: Insight into the mechanisms by which metoclopramide improves immune function after trauma-hemorrhage. Am J Physiol Cell Physiol 2000;279:C72-C80.
3. Dardenne M, DeMoraes M, Kelly P, Gagnerault M: Prolactin receptor expression in human hematopoietic tissues analyzed by flow cytometry. Endocrinology 1994;134:2108-2114.
4. Bellone G, Astarita P, Artusio E, Silvestri A, Mareschi K, Turletti A, Buttigerlieri S, Emanvella G, Matera L: Bone marrow stroma-derived prolactin is involved in basal and platelet activating factor-stimulated in vitro erythropoiesis. Blood 1997;90:21-27.
5. Welniak L, Richards S, Murphy W: Effects of prolactin on hematopoiesis. Lupus 2001;10:700-705.
6. Woody M, Welniak L, Sun R, Tian Z, Henry M, Richards S, Murphy W: Prolactin exerts hematopoietic growth-promoting effects in vivo and partially counteracts myelosuppression by AZT. Exp Hematol 1999;27:811-816.
7. Richards SM, Murphy WJ: Use of human prolactin as a therapeutic protein to potentiate immunohematopoietic function. J Neuroimmunol 2000;109:56-62.
8. Dugan AL, Thellin O, Buckley DJ, Buckley AR, Ogle CK, Horseman ND: Effects of prolactin deficiency on myelopoiesis and splenic T lymphocyte proliferation in thermally injured mice. Endocrinology 2002;143:4147-4151.
9. Dugan AL, Schwemberger S, Babcock GF, Buckley DJ, Buckley AR, Ogle CK, Horseman ND: Effects of prolactin level on burn-induced aberrations in myelopoiesis. Shock 2004;21:151-159.
10. Horseman ND, Zhao W, Montecino-Rodriguez E, Tanaka M, Nakashima K, Engle S, Smith F, Markoff E, Dorshkind K: Defective mammopoiesis, but normal hematopoiesis in mice with a targeted disruption of the prolactin gene. EMBO J 1997;16:6926-6935.
11. Dorshkind K, Horseman N: The roles of prolactin, growth hormone, insulin-like growth factor-1, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency. Endocr Rev 2000;21:1-21.
12. Fomicheva EE, Nemirovich-Danchenko EA, Korneva EA: Immunoprotective effects of prolactin during stress-induced immune dysfunction. Bull Exp Biol Med 2004;6:544-547.
13. Kiecolt-Glaser JK, Glaser R: Psychoneuroimmunology and health consequences: data and shared mechanisms. Psychosom Med 1995;57:269-274.
14. Malacrida SA, Teixeira NA, Queiroz ML: Hematopoietic changes in rats after inescapable and escapable shocks. Immunopharmacol Immunotoxical 1997;19:523-533.
15. Engler H, Bailey MT, Engler A, Sheridan JF: Effects of repeated social stress on leukocyte distribution in bone marrow, peripheral blood and spleen. J Neuroimmunol 2004;148:106-115.
16. Laakko T, Fraker P: Rapid changes in the lymphopoietic and granulopoietic compartments of the marrow caused by stress levels of corticosterone. Immunology 2002;105:111-119.
17. Blanchard RJ, Nikulina JN, Sakai RR, Mc-Kittrick C, McEwen B, Blanchard DC: Behavioral and endocrine changes following chronic predatory stress. Physiol Behav 1998;63:561-569.
18. Tanaka T, Shiu RP, Gout PW, Beer CT, Noble RL, Friesen HG. A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum. J Clin Endocrinol Metab 1980;51:1058-1063.
19. Lu ZW, Song C, Ravindran AV, Merali Z, Anisman H: Influence of psychogenic and neurogenic stresses on several indices of immune functioning in different strains of mice. Brain Behav Immun 1998;12:7-22.
20. Anisman H, Hayley S, Kelly O, Borowski T, Merali Z: Psychogenic, neurogenic, and systemic stressor effects on plasma corticosterone and behavior: mouse strain-dependent outcomes. Behav Neurosci 2001;115:443-454.
21. Drago F, Continella G, Scapagnini U: Behavioral and neurochemical changes in long-term hyperprolactinemia; in Kemali D, Racagni G (eds): Chronic Treatments in Neuropsychiatry. New York, Raven Press, 1985, pp 47-58.
22. Drago F, Pulvirenti L, Spadaro F, Pennisi G: Effects of TRH and prolactin in the behavioral despair (swim) model of depression in rats. Psychoneuroendocrinology 1990;15:349-356.
23. Shoup M, Weisenberger J, Wang J, Pyle J, Gamelli R, Shankar R: Mechanisms of neutropenia involving myeloid maturation arrest in burn sepsis. Ann Surg 1998;228:112-122.
24. Santangelo S, Gamelli R, Shankar R: Myeloid commitment shifts toward monocytopoiesis after thermal injury and sepsis. Ann Surg 2001;233:97-106.
25. Rohrschneider LR, Metcalf D: Induction of macrophage colony-stimulating factor-dependent growth and differentiation after introduction of the murine c-fms gene into FDC-P1 cells. Mol Cell Biol 1989;9:5081-5092.
26. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006;354:610-621.
27. Nagy E, Berczi I: Hypophysectomized rats depend on residual prolactin for survival. Endocrinology 1991;128:2776-2784.
28. Bouchard B, Ormandy C, DiSanto J, Kelly P: Immune system development and function in prolactin receptor deficient mice. J Immunol 1999;163:576-582.
29. Stocklin E, Wissler M, Gouilleux F, Groner B: Functional interactions between Stat5 and the glucocorticoid receptor. Nature 1996;383:726-728.
30. Krishnan N, Thellin O, Buckley DJ, Horseman ND, Buckley AR: Prolactin suppresses glucocorticoid-induced thymocyte apoptosis in vivo. Endocrinology 2003;144:2102-2110.
31. Windle RJ, Wood S, Shanks N, Perks P, Conde GL, daCosta A, Ingram C, Lightman S: Endocrine and behavioural responses to noise stress: comparison of virgin and lactating female rats during non-disrupted maternal activity. J Neuroendocrinol 1997;9:407-414.
32. 2 challenge in postpartum women. Clin Endocrinol (Oxf) 2004;61:582-588.
33. Neumann I: Brain mechanisms underlying emotional alterations in the peripartum period in rats. Depress Anxiety 2003;17:111-121.
34. Torner L, Toschi N, Pohlinger A, Landgraf R, Neumann I: Anxiolytic and anti-stress effects of brain prolactin: improved efficacy of antisense targeting of the prolactin receptor by molecular modeling. J Neurosci 2001;21:3207-3214.
35. Schlein P, Zarrow M, Denenberg V: The role of prolactin in the depressed or 'buffered' adrenocorticosteroid response of the rat. J Endocrinol 1974;62:93-99.
36. Maruyama S, Minagawa M, Shimizu T, Oya H, Yamamoto S, Musha N, Abo W, Weerasinghe A, Hatakeyama K, Abo T: Administration of glucocorticoids markedly increases the numbers of granulocytes and extrathymic T cells in the bone marrow. Cell Immunol 1999;194:28-35.
37. Meli R, Raso GM, Bentivoglio C, Nuzzo I, Galdiero M, Di Carlo R: Recombinant human prolactin induces protection against Salmonella typhimurium infection in the mouse: role of nitric oxide. Immunopharmacology 1996;34:1-7.
38. Walker S, Jacobson J: Roles of prolactin and gonadotropin-releasing hormone in rheumatic diseases. Rheum Dis Clin North Am 2000;26:713-736.
39. Tworoger SS, Sluss P, Hankinson SE: Association between plasma prolactin concentrations and risk of breast cancer among predominantly premenopausal women. Cancer Res 2006;66:2476-2482.